Quarterly report also reveals 29% of approvals contained an immune checkpoint inhibitor and 43% were biomarker dependent ATLANTA – [September 27, 2021] – OncoHealth, the leading digital health company focused on the physical, mental and financial...
New name comes on the heels of major growth period and reflects the company’s expanding digital health portfolio ATLANTA – [September 20, 2021] – Oncology Analytics, the evidence-based digital health company purpose-built for oncology, announced today that...